Winklevoss Capital led a $58.88 million private placement last October in Leap Therapeutics, the biotechnology company that later renamed itself Cypherpunk Technologies

From the articleWinklevoss Zcash ETF Could Become the Second U.S. Spot ZEC Fund After Grayscale's ZCSH - Unchained